Detalhe da pesquisa
1.
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
Br J Cancer
; 130(3): 434-441, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102226
2.
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide.
Prostate
; 83(4): 376-384, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564933
3.
Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study.
Br J Cancer
; 128(1): 21-29, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289372
4.
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
BMC Cancer
; 23(1): 1056, 2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919668
5.
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Lancet Oncol
; 23(2): 248-258, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030333
6.
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 381(4): 338-348, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340094
7.
Laparoscopic Right Adrenalectomy in a Large Right Adrenal Oncocytic Carcinoma.
Ann Surg Oncol
; 28(5): 2765, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33244737
8.
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet
; 393(10189): 2404-2415, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079938
9.
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer.
Int J Cancer
; 145(7): 1970-1981, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30807643
10.
Radium-223 international early access program: results from the Spanish subset.
Future Oncol
; 14(1): 41-50, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29232987
11.
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.
Lancet Oncol
; 18(5): 672-681a, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389316
12.
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
BMC Cancer
; 16: 135, 2016 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26906039
13.
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial.
Lancet Oncol
; 16(15): 1473-1482, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26482279
14.
REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis.
Future Oncol
; 11(21): 2893-903, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26376939
15.
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.
Mol Cancer
; 13: 237, 2014 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25331979
16.
Dual inhibition of MEK and PI3Kß/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.
Front Pharmacol
; 15: 1331648, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318136
17.
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.
Clin Cancer Res
; 30(8): 1630-1641, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319672
18.
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Eur Urol Oncol
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429210
19.
Evaluation of patients with metastatic renal cell carcinoma after failure of first-line treatment.
Cancer Metastasis Rev
; 31 Suppl 1: S3-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22689342
20.
Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer.
Prostate
; 73(5): 512-21, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23038213